Kaas, have quite frankly believed too much of your and other CYTX die-hard investors have over relied on faith and suspended realistic analysis of CYTX relative to other competitors. Nonetheless, I sincerely hope that faith is rewarded in 2013 with technology promise overwhelming management and balance sheet deficiencies. Ischemia or MI could be the high value indications that lead to fulfillment of that promise. Best wishes for a nice payday should that occur.
Kaas, I sincerely hope that your predictions for 2013 are realised. It has been a long time coming, but CYTX is now substantially closer to lift off than most people realise. Once this stock enters the broader markets sights, irregardless of the catalyst, analysts and investors will be infatuated with the range of medical indications this technology will be able to address.
As for your reasons that 2013 will be a turnaround year I agree with the 1st ie. Call for Evidence.
I am not sure about the second. Dean would not have made a statement like 10XWD if he did not believe in the technology and that the managements approach was the correct one. Obviously there were obstacles and in the imortal words of someone whose name I do not know said, "excrement happens" . Thats the reason I no longer use options or margin.
Given that the shareprice is a reflection of our dreams and that CYTX has gone as low as 2.46 since the BARDA deal was announced, this constitutes a realised worst nightmare scenario for most of us. I would like to modify Mr Dean's forecast and propose that 2013 finds CYTX investors realising 10 times there worst nightmare ie $24.60. As for my wildest dreams I keep them to myself for fear of being thought ridiculous.